Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Machine Learning-Assisted Rapid Optical Imaging for Label-Free CAR T-Cell Detection in Whole Blood.
Journal: Biosensors
Published: January 20, 2026
Impact of granulocyte colony-stimulating factor on safety of chimeric antigen receptor-T-cell therapy in non-Hodgkin lymphoma.
Journal: British journal of haematology
Published: March 11, 2025
Off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy in relapsed or refractory B-cell lymphoma: a multicentre, open-label, phase 1 study.
Journal: The Lancet. Haematology
Published: March 05, 2025
Hypomagnesemia in lymphoma patients receiving CAR T therapy correlates with immune dysfunction and decreased survival.
Journal: Experimental hematology & oncology
Published: December 27, 2024
Cellular therapies in rheumatic and musculoskeletal diseases.
Journal: Journal of translational autoimmunity
Published: October 29, 2024
CAR T-cell therapy landscape in pediatric, adolescent and young adult oncology - A comprehensive analysis of clinical trials.
Journal: Critical reviews in oncology/hematology
Published: October 15, 2024
Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 10, 2023
Evaluating the Patient with Neurotoxicity after Chimeric Antigen Receptor T-cell Therapy.
Journal: Current treatment options in oncology
Published: October 30, 2022
Aberrant spliceosome activity via elevated intron retention and upregulation and phosphorylation of SF3B1 in chronic lymphocytic leukemia.
Journal: Molecular therapy. Nucleic acids
Published: July 14, 2022
Extracorporeal photopheresis for the treatment of chronic graft versus host disease.
Journal: Hematology (Amsterdam, Netherlands)
Published: July 08, 2022
Last Updated: 09/26/2026